scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1001/JAMA.1990.03440160066039 |
P698 | PubMed publication ID | 2157078 |
P50 | author | Michael Ellis DeBakey | Q335003 |
P2093 | author name string | J L Melnick | |
E Adam | |||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cytomegalovirus | Q6946 |
P304 | page(s) | 2204-2207 | |
P577 | publication date | 1990-04-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Possible role of cytomegalovirus in atherogenesis | |
P478 | volume | 263 |
Q35833368 | Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. |
Q33588514 | Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes |
Q38636550 | Arterial Stiffness Is Associated With Cytomegalovirus-Specific Senescent CD8+ T Cells |
Q73423924 | Atherosclerosis and arteriosclerosis in chronic renal failure |
Q44002732 | B-cell activation following murine cytomegalovirus infection: implications for autoimmunity |
Q74571458 | CMV infection and allograft rejection |
Q33560856 | Cardiac transplantation: a review for critical care nurses |
Q77644021 | Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved |
Q35830821 | Characterization of human vascular smooth muscle cells transformed by the early genetic region of SV40 virus |
Q33709008 | Coagulation initiated on herpesviruses |
Q30245376 | Cytomegalovirus and HIV: A Dangerous Pas de Deux |
Q34294809 | Cytomegalovirus infection and cardiac allograft vasculopathy |
Q34169756 | Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts |
Q36119334 | Cytomegalovirus localization in atherosclerotic plaques is associated with acute coronary syndromes: report of 105 patients |
Q35831056 | Cytomegalovirus nucleic acid distribution within the human vascular tree |
Q48876969 | Detection of human cytomegalovirus in atherosclerotic carotid arteries in humans |
Q54008411 | Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response. |
Q37880581 | Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction |
Q64066073 | Evaluation of the relationship between plaque formation leading to symptomatic carotid artery stenosis and cytomegalovirus by investigating the virus DNA |
Q35830374 | Genetic determination of cytomegalovirus-induced and age-related cardiopathy in inbred mice. Characterization of infiltrating cells |
Q33292028 | HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasia |
Q38007417 | HIV infection and atherosclerosis: evaluating the drivers of inflammation |
Q37361231 | Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells |
Q37967568 | Human cytomegalovirus infection and atherothrombosis |
Q53033703 | Imaging atherosclerotic burden and inflammation: insights into the spectrum of atherosclerotic disease in HIV. |
Q35160580 | Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. |
Q31915357 | Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk |
Q37879391 | Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae |
Q89459124 | Infection and atherosclerosis: TLR-dependent pathways |
Q33936406 | Infectious burden: a new risk factor and treatment target for atherosclerosis |
Q46016322 | Inflammation and Fibrosis in HIV: Getting to the Heart of the Matter. |
Q33871329 | Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease? |
Q34235537 | Inflammatory Mechanisms of Stroke |
Q33784977 | Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection |
Q46297555 | Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus |
Q27478450 | Modulation of major histocompatibility complex antigen expression by viral infection |
Q33827354 | Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage |
Q36181163 | Persistent infection and vascular disease: a systematic review |
Q40436428 | Possible Role of Viruses in Atherosclerosis |
Q28193489 | Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression |
Q41129100 | Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration |
Q35465943 | Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients |
Q92885360 | Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection |
Q41212001 | The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus |
Q73468006 | The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection |
Q42839679 | Transformation of rabbit vascular smooth muscle cells by human cytomegalovirus morphological transforming region I |
Q71833504 | Transient severe myocardial ischemia during septic shock in a young woman with AIDS |
Q33762104 | Viruses and atherosclerosis: a critical review of the epidemiologic evidence |